Insilico Medicine

Hong Kong’s Insilico Medicine bags new investment led by Aramco-backed Prosperity7 Ventures

Insilico Medicine, a Hong Kong-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced Wednesday that it has completed a second…

Insilico Medicine closes $255M Series C led by Warburg Pincus to further develop AI and drug discovery

Insilico Medicine, an AI-based platform for drug development and discovery headquartered in Hong Kong, announced that it has closed a $255 million Series C funding round led by…